Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bidlingmaier

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Thrombosis and Haemostasis : JTH|September 6, 2018
The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTHM E Mancuso, C Bidlingmaier, J N Mahlangu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 3, 2009
New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor developmentK Kurnik, C Bidlingmaier, W Engl, et al.
Hamostaseologie|September 11, 2012
Arterial thrombosis in homozygous antithrombin deficiencyM Olivieri, C Bidlingmaier, S Schetzeck, et al.
Hamostaseologie|November 3, 2010
Postoperative bleeding in paediatric ENT surgery. First results of the German ESPED trialC Bidlingmaier, M Olivieri, K Stelter, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 1, 2018
Prospects for research in haemophilia with real-world data-An analysis of German registry and secondary dataD Schopohl, C Bidlingmaier, D Herzig, et al.
Cytokine|March 8, 2000
High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive proteinG Hartmann, M Tschöp, R Fischer, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in miceG Hartmann, C Bidlingmaier, B Siegmund, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 9, 2011
Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia AC Bidlingmaier, K Kurnik, C Escuriola-Ettingshausen, et al.
European Journal of Clinical Investigation|May 6, 1998
Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphismsU T Hacker, C Bidlingmaier, M Gomolka, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2000
Adenosine kinase inhibitor GP515 improves experimental colitis in miceB Siegmund, F Rieder, S Albrich, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Thrombosis and Haemostasis : JTH|September 6, 2018
The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTHM E Mancuso, C Bidlingmaier, J N Mahlangu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 3, 2009
New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor developmentK Kurnik, C Bidlingmaier, W Engl, et al.
Hamostaseologie|September 11, 2012
Arterial thrombosis in homozygous antithrombin deficiencyM Olivieri, C Bidlingmaier, S Schetzeck, et al.
Hamostaseologie|November 3, 2010
Postoperative bleeding in paediatric ENT surgery. First results of the German ESPED trialC Bidlingmaier, M Olivieri, K Stelter, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 1, 2018
Prospects for research in haemophilia with real-world data-An analysis of German registry and secondary dataD Schopohl, C Bidlingmaier, D Herzig, et al.
Cytokine|March 8, 2000
High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive proteinG Hartmann, M Tschöp, R Fischer, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in miceG Hartmann, C Bidlingmaier, B Siegmund, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 9, 2011
Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia AC Bidlingmaier, K Kurnik, C Escuriola-Ettingshausen, et al.
European Journal of Clinical Investigation|May 6, 1998
Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphismsU T Hacker, C Bidlingmaier, M Gomolka, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2000
Adenosine kinase inhibitor GP515 improves experimental colitis in miceB Siegmund, F Rieder, S Albrich, et al.
Pageof 3